bluuebunny/crossref_metadata_2025_split huggingface dataset:
An empirical investigation on waqf governance practices in waqf institutions in Malaysia
Authors: Kamaruddin Muhammad Iqmal Hisham , Hanefah Mustafa Mohd 
Published: May 2021

Purpose
This study aims to examine and compare the current waqf governance practices in waqf institutions in Malaysia.

Design/methodology/approach
This paper reviews professional documents and literature to propose a new and practical waqf governance measurement. Waqf governance measurements were used to examine and compare the current waqf governance practices among waqf institutions in Malaysia. The annual reports of all waqf institutions under the State Islamic Religious Councils (SIRCs) were analysed using content analysis on the current waqf governance practices using binomial logic.

Findings
Overall, the results indicate moderate waqf governance practices under three waqf governance categories, namely waqf governance policy, waqf governance board and waqf governance processes. This study also found a significant impact of corporatisation reformation of waqf institutions on waqf governance practices.

Research limitations/implications
The findings indicate the need for all waqf institutions in Malaysia, especially for non-corporate waqf institutions, to enhance their waqf governance practices by disclosing all relevant information to the public. This is because the success of waqf fund management can be portrayed through the management’s transparency in waqf governance practices on how they deliver and use their resources to attain socio-economic objectives.

Originality/value
To the best of the authors’ knowledge, this study is among the first studies that examined and evaluated the current waqf governance practices in several waqf institutions in Malaysia.
Open innovation antecedents and its consequences on commercialization performance in small and medium-sized enterprises
Authors: Asgari Mohammad Javad , Zakery Amir , Pishvaee Mir Saman 
Published: May 2021

PurposeThis paper aims to investigate the impact of the factors affecting open innovation (OI) intensity, in terms of three components of cooperative innovation, resource search and external research and development (R&D), as well as the impact of OI intensity on commercialization performance in small and medium-sized enterprises.Design/methodology/approachThe data obtained from the distributed questionnaire among small and medium-sized enterprises (SMEs) from Isfahan Science and Technology Town (ISTT) in Iran, was analyzed using inferential and parametric statistics to examine the research hypotheses. In this analysis, structural equation tests were used to confirm or reject the research hypotheses using Smart PLS software.FindingsThe results indicate that all three OI components influence commercialization in technology-based firms of ISTT, while the most important one is cooperative innovation. Among the factors affecting OI components, innovative incentives are the most effective one that increases both external R&D and cooperative innovation. Facilitators and limitations of open innovation are also affecting OI intensity, with lower priorities.Practical implicationsScience park managers and policymakers should lay the ground for enhancing the cooperation intensity among firms. Cooperation intensity is the most effective open innovation component to improve commercialization performance.Originality/valueOpen innovation antecedents and its consequence on commercialization performance have been investigated for the same time in SMEs of a science park.
Cross-sector collaboration and nonprofit boundary work for female workers in developing countries: evidence from Bangladesh
Authors: Fontana Enrico , Heuer Mark , Koep Lisa 
Published: May 2021

Purpose
The purpose of this paper is to shed new light on the way the cross-sector collaboration (CSC) process can foster gender-focused sustainability initiatives to improve female workers’ conditions in developing countries. The study does so by introducing and examining the influence of nonprofit boundary work during the CSC process.

Design/methodology/approach
The paper is based on thirty-four interviews and qualitative fieldwork. It draws on a case analysis of a regional CSC between multiple organizations operating locally in the apparel industry of Bangladesh, a developing country.

Findings
Scaffolding work in the CSC formation stage – performed by development agency implementers who construe boundaries – and sensitization work in the CSC implementation stage – performed by a non-governmental organization (NGO) implementers who blur and expand boundaries – emerge as two conceptual categories of nonprofit boundary work. This allows NGO implementers to identify and enable the agency of sustainability envoys or socially privileged individuals who capitalize on their social credentials to support female workers in the factory and in the community.

Originality/value
The study offers novel insights into the CSC process. It contributes to the CSC literature and the literature on boundary work, with a focus on gender-focused sustainability initiatives for female workers in developing countries.
Systemic risk contagion within US states
Authors: Choudhury Tonmoy , Daly Kevin 
Published: May 2021

PurposeThis study aims to examine the systemic risk contagion in banks from 15 US states using extreme shocks in their distance to risk.Design/methodology/approachThe authors contemplate a model that inputs co-exceedances in the base US states’ banking sector as the dependent variable and the co-exceedances in other states’ banking sector (along with other underlying variables of a banking system) as the explanatory variables.FindingsThe authors find smaller states transmit and receive more systemic shocks than their larger counterparts and larger states exhibit a better shock-resisting capacity than their smaller counterparts. The authors also find that bigger shocks are more contagious than the smaller shocks.Originality/valueThis will be the first paper that will investigate the inner linkage of US states’ banking network using three different distance to risk methods, thus providing timely guidance for regulators.
Hydroa vacciniforme‐like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China
Authors: Wang Xinhua , Liang Yuanzheng , Yang Yanxin , Li Wencai , Wang Guannan , Wang Shuangfeng , Li Yan , Zhang Mingzhi 
Published: May 2021

AbstractHydroa vacciniforme‐like lymphoproliferative disorder (HV‐LPD) is a rare cutaneous disease associated with Epstein–Barr virus infection. We retrospectively analyzed the clinical presentation, histopathological characteristics, and prognostic study of HV‐LPD in 24 Chinese patients. All patients presented with recurrent papulovesicular and necrotic eruptions on the face, neck, and extremities, with 11 showing systemic symptoms. Twenty patients were diagnosed with HV‐LPD in childhood (age < 18 years) and four in adulthood (age ≥ 18 years). The median age at diagnosis was 8.5 years old (range, 2–50). Histopathology revealed variably dense lymphocyte infiltration throughout the dermis. All cases were strongly positive for CD3 and Epstein–Barr encoding region based onin situhybridization. Of 18 cases with a T‐cell phenotype, 15 harbored monoclonal rearrangements in T‐cell receptor (TCR) genes. Four cases with a natural killer cell phenotype carried polyclonal rearrangements in TCR genes. Among 24 patients, eight (33.3%) received chemotherapy, two (8.3%) allogeneic hematopoietic stem cell transplantation, and both are currently alive without disease. The median follow‐up period was 24 months (range, 7–120) and 23 patients were available: 15 (62.5%) were alive, and eight (33.3%) had died. Fourteen cases had a relapse of disease and three developed lymphoma within 24 months of diagnosis. The mean survival time of childhood‐onset patients was longer than that of adult‐onset patients (36.4 vs. 20.8 months). In summary, the wide clinical course and representative presentation of cases in our center reflect the pedigree characteristics of HV‐LPD. Allogeneic hematopoietic stem cell transplantation should be a preferred choice for relapse and refractory patients due to the poor effect of chemotherapy. Adult‐onset and high serum EBV DNA loads may indicate an increased risk of aggressive disease in patients with HV‐LPD.
Recommendations for COVID‐19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists
Authors: Santosa Amelia , Xu Chuanhui , Arkachaisri Thaschawee , Kong Kok Ooi , Lateef Aisha , Lee Tau Hong , Leong Keng Hong , Low Andrea Hsiu Ling , Sriranganathan Melonie K. , Tan Teck Choon , Teng Gim Gee , Thong Bernard Yu‐hor , Fong Warren , Lahiri Manjari 
Published: May 2021

AbstractAimPeople with rheumatic diseases (PRD) remain vulnerable in the era of the COVID‐19 pandemic. We formulated recommendations to meet the urgent need for a consensus for vaccination against SARS‐CoV‐2 in PRD.MethodsSystematic literature reviews were performed to evaluate: (a) outcomes in PRD with COVID‐19; (b) efficacy, immunogenicity and safety of COVID‐19 vaccination; and (c) published guidelines/recommendations for non‐live, non‐COVID‐19 vaccinations in PRD. Recommendations were formulated based on the evidence and expert opinion according to the Grading of Recommendations Assessment, Development and Evaluation methodology.ResultsThe consensus comprises 2 overarching principles and 7 recommendations. Vaccination against SARS‐CoV‐2 in PRD should be aligned with prevailing national policy and should be individualized through shared decision between the healthcare provider and patient. We strongly recommend that eligible PRD and household contacts be vaccinated against SARS‐CoV‐2. We conditionally recommended that the COVID‐19 vaccine be administered during quiescent disease if possible. Immunomodulatory drugs, other than rituximab, can be continued alongside vaccination. We conditionally recommend that the COVID‐19 vaccine be administered prior to commencing rituximab if possible. For patients on rituximab, the vaccine should be administered a minimum of 6 months after the last dose and/or 4 weeks prior to the next dose of rituximab. Post‐vaccination antibody titers against SARS‐CoV‐2 need not be measured. Any of the approved COVID‐19 vaccines may be used, with no particular preference.ConclusionThese recommendations provide guidance for COVID‐19 vaccination in PRD. Most recommendations in this consensus are conditional, reflecting a lack of evidence or low‐level evidence.
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report
Authors: Kuge Tomoki , Okabe Fukuko , Yamamoto Yuji , Ishijima Mikako , Uenami Takeshi , Kanazu Masaki , Akazawa Yuki , Yano Yukihiro , Yamaguchi Toshihiko , Mori Masahide 
Published: May 2021

AbstractPulmonary pleomorphic carcinoma is a rare malignant tumor that grows rapidly and has a poor prognosis. Although no effective treatments have so far been established, immune checkpoint inhibitors (ICIs) have shown clinical improvement in some cases of pleomorphic carcinoma. However, pseudoprogression is a major concern for treatment of this carcinoma using ICIs. Here, we report the case of a 61‐year‐old man who was diagnosed with large cell carcinoma of the lung with brain metastases. Systemic chemotherapy comprising carboplatin and pemetrexed was administered as a first‐line therapy; however, disease progression was observed. A tonsillar lesion grew rapidly after the administration of nivolumab as a second‐line therapy. Tracheostomy was planned to avoid suffocation, but the patient naturally expectorated the tumor. Pathological examination revealed that it was a palatine tonsillar metastasis of pulmonary pleomorphic carcinoma with infiltration of CD8+/CD4‐ lymphocytes and necrosis. The primary lesion expanded after nivolumab administration and shrank with no additional nivolumab administration. We therefore concluded that pseudoprogression caused expectoration of the tonsillar metastasis. Hence, ICIs can cause serious adverse events due to pseudoprogression.
Cattle, climate and complexity: food security, quality and sustainability of the Australian cattle industries
Authors: Lean IJ , Moate PJ 
Published: May 2021

BackgroundMarked increases in atmospheric CO2 concentrations are largely associated with the release of sequestered carbon in fossil fuels. While emissions of green‐house gasses (GHG) from cattle have significant global warming potential, these are biogenic sources and substantially involve carbon in natural cycles, rather than fossil fuel. Cattle use human inedible feeds and by‐products of human food production to produce nutrient‐dense foods of great value to humans.Interventions to reduce GHG productionReductions in land clearing and burning of grasslands and increased carbon sequestration in soils and trees have potential to substantially reduce GHG emissions. Increased efficiencies of production through intensified feeding and enteric modification have markedly reduced intensity of GHG emissions for cattle in Australia. Genetic selection for lower emissions has modest, but cumulative potential to reduce GHG (mostly CH4) emissions and intensity. Improved reproductive performance can reduce intensity of GHG emissions, especially in beef production. Feeds and technologies that reduce GHG production and intensity include improved pastures, grain feeding, dietary lipids, nitrates, ionophores, seaweed, 3‐NOP, hormonal growth promotants in beef, and improved diets for peri‐parturient dairy cattle. There is considerable potential to further reduce emissions from cattle using the technologies reviewed.Interventions to reduce heat stressCattle are susceptible to heat stress and ameliorating interventions include tree and shelter belts, shade, housing, cooling with fans and water and dietary manipulations.ConclusionsNumerous interventions can reduce GHG emissions and intensity from cattle. There are opportunities to increase carbon capture and maintain biodiversity in Australia's extensive rangelands, but these require quantification and application. We can reduce the intensity of CH4 emissions for cattle in Australia and simultaneously improve their well‐being.
An exploration of how gender stereotypes influence how practitioners identify and respond to victims (or those at risk) of child sexual exploitation
Authors: Hill Lauren , Diaz Clive 
Published: May 2021

AbstractChild sexual exploitation (CSE) has been found to have a detrimental and long‐lasting impact upon a victim's physical and emotional well‐being. A large body of research has raised concerns about how practitioners identify and respond to CSE. In particular, research has indicated that male victims of CSE are commonly being overlooked by practitioners. It has been suggested that this may occur as a result of gender stereotypes. However, this has not been specifically explored by existing research. Therefore, this research project explored how gender stereotypes may influence how practitioners identify and respond to children and young people who are victims (or at risk) of CSE. Semi‐structured interviews were conducted with eight practitioners from one Youth Offending Service in the South West of England. Three key themes emerged from the interviews. These themes highlight that as a result of gender stereotypes, practitioners may be less likely and/or slower to identify males as victims and may be less likely to provide males with supportive multi‐agency responses. This paper makes recommendations about how this issue can be addressed to ensure that all victims of CSE are adequately safeguarded.
Child welfare in non‐metro and rural communities: Experiences of child‐serving professionals addressing substance use
Authors: Orsi Rebecca , Boissy Lauren , Yuma Paula , Palmer Fred , Torres‐Molinar Stephanie 
Published: May 2021

AbstractThe purpose of this study is to explore the challenges and strengths that child welfare professionals experience in non‐metro areas, with a secondary focus on how they encounter and respond to substance use in families and communities. We conducted three focus groups in non‐metro counties (n = 35). We used thematic analysis supported by Dedoose, beginning with line by line coding, then thematic identification and mapping. Emergent themes focused on challenges and strengths experienced in non‐metro communities, including (Community context)—unique community attributes; the call for treatment; (Challenges)—uphill battles; reporting; access to appropriate care; funding; interacting with state systems; and (Strength)—finding strengths and creative solutions. Child welfare professionals in non‐metro communities embody and respond to both challenges and strengths. They feel frustrated by standards that do not take available resources into account, yet they effectively leverage social capital to complete their work. Giving voice to child welfare professionals can enhance policy making and create more sustainable systems for child welfare practice in non‐metro settings.
Design and conduct considerations for studies in patients with impaired renal function
Authors: Ravenstijn Paulien , Chetty Manoranjenni , Manchandani Pooja 
Published: May 2021

AbstractAn impaired renal function, including acute and chronic kidney disease and end‐stage renal disease, can be the result of aging, certain disease conditions, the use of some medications, or as a result of smoking. In patients with renal impairment (RI), the pharmacokinetics (PKs) of drugs or drug metabolites may change and result in increased safety risks or decreased efficacy. In order to make specific dose recommendations in the label of drugs for patients with RI, a clinical trial may have to be conducted or, when not feasible, modeling and simulations approaches, such as population PK modeling or physiologically‐based PK modelling may be applied. This tutorial aims to provide an overview of the global regulatory landscape and a practical guidance for successfully designing and conducting clinical RI trials or, alternatively, on applying modeling and simulation tools to come to a dose recommendation for patients with RI in the most efficient manner.
Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
Authors: Idris Iskandar , Zhang Ruiqi , Mamza Jil Billy , Ford Mike , Morris Tamsin , Banerjee Amitava , Khunti Kamlesh 
Published: May 2021

AbstractAimTo assess if sodium‐glucose co‐transporter‐2 inhibitors (SGLT2is) reduce the risk of all‐cause mortality, cardiovascular death and hospitalization for heart failure (HF) or chronic kidney disease (CKD) to a greater extent than dipeptidyl peptidase‐4 inhibitors (DPP4is) in people with type 2 diabetes (T2D) with or without established cardiovascular and/or renal disease (CVRD).MethodsThis retrospective cohort study propensity‐matched 24 438 patients receiving an SGLT2i 1:1 to a patient receiving a DDP4i, stratified based on the presence of CVRD. The primary outcomes were the time to each of the following: all‐cause mortality, cardiovascular death or hospitalization for HF, myocardial infarction, stroke and CKD.ResultsOverall, SGLT2is were associated with reductions in all‐cause mortality, cardiovascular mortality, hospitalization for HF and hospitalization for CKD compared with DPP4is. In patients with no CVRD history, SGLT2is were associated with reductions in all‐cause mortality (HR 0.71, 95% CI 0.57‐0.88; P = .002), hospitalization for HF (HR 0.76, 95% CI 0.59‐0.98; P = .035) and hospitalization for CKD (HR 0.75, 95% CI 0.63‐0.88; P < .001). In patients with established cardiovascular disease (CVD) or at high risk, SGLT2is were associated with reductions in all‐cause mortality (HR 0.69, 95% CI 0.59‐0.82; P < .001), cardiovascular mortality (HR 0.76, 95% CI 0.62‐0.95; P = .014), hospitalization for HF (HR 0.73, 95% CI 0.63‐0.85; P < .001), hospitalization for stroke (HR 0.75, 95% CI 0.59‐0.94; P = .013) and hospitalization for CKD (HR 0.49, 95% CI 0.43‐0.54; P < .001).ConclusionThere was consistency across subgroups and sensitivity analyses. SGLT2is were associated with a reduced risk of all‐cause mortality and hospitalization for HF and CKD compared with DPP4‐is, highlighting the need to introduce SGLT2is early in the management of patients with T2D.
Correlation of echocardiographic parameters in prone and supine positions in normal adults using a novel approach
Authors: Taha Hesham S. , Mohamed Ahmed M. , Mahrous Hossam A. , Shaker Mirna M. , Alsayed Osama S. , Sayed Hadeer G. , Rizk Hussien H. , Abdelwahab Mohamed A. 
Published: May 2021

AbstractBackgroundTransthoracic echocardiography (TTE) in prone position is challenging. Innovative use of transesophageal echocardiography (TEE) probe to perform TTE for such patients has been described; but reproducibility and correlation of the TTE measurements by this technique with those obtained by the standard supine TTE study are still unknown.MethodsWe enrolled 30 non–COVID‐19 individuals, with a mean (SD) age 35 (10.9) years and 11 females, to study the agreement between the transthoracic measurements of the left ventricular (LV), left atrial (LA), aortic dimensions, and ejection fraction (EF) obtained in prone position using an external TEE probe versus the standard supine position using the conventional TTE probe.ResultsThere were no significant differences between LV end‐diastolic and end‐systolic diameters, septal wall thickness, posterior wall thickness, and aortic root dimensions in the prone versus the supine positions, while the mean EF (60.3% vs 63.1%, P = .014) and mean LA dimensions (1.8 vs 1.9 cm/m2, P < .001) were significantly lower in the prone position. The mean time of scans was significantly longer in the prone as compared to the supine position (12.5 vs 4.5 minutes, P < .001). All supine studies had good quality while in the prone position four studies were of poor quality, and one was nondiagnostic.ConclusionsAssessment of cardiac dimensions and systolic function in the prone position using transthoracic TEE probe was feasible. LV and aortic dimensions agreed well with the standard TTE in supine position; however, LA dimensions and EF were lower in the prone position.
Unexpected pacemaker lead in an 84‐year‐old patient
Authors: Sams Lauren , Brunner Stefan , Näbauer Michael , Steffen Julius 
Published: May 2021

AbstractAn elderly patient with a history of atrial fibrillation presented to our emergency room. Previous medical records from another hospital described a pacemaker lead in the echocardiography although the patient had no known history of a pacemaker implantation. Finally, by close examination, chest X‐ray, and computed tomography, we found that a kyphoplasty of the spine had caused a so‐called palacos embolism, which had repeatedly been mistaken for a pacemaker lead. Unusually, there were no further signs of kyphoplasty material in the pulmonary veins. As the patient was asymptomatic and the embolism caused only moderate tricuspid regurgitation, a conservative treatment was agreed on.